John P Zimmer, the EVP of $CMT ($CMT), sold 2,100 shares of the company on 11-26-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.1% of their shares. Following this trade, they now own 95,859 shares of $CMT stock.
$CMT Insider Trading Activity
$CMT insiders have traded $CMT stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $CMT stock by insiders over the last 6 months:
- JOHN P ZIMMER (EVP, Treasurer, Secretary, CFO) has traded it 8 times. They made 0 purchases and 8 sales, selling 61,769 shares.
- RENEE R ANDERSON (EVP, Human Resources) has traded it 10 times. They made 0 purchases and 10 sales, selling 39,007 shares.
- DAVID L. DUVALL (Chief Executive Officer) has traded it 5 times. They made 0 purchases and 5 sales, selling 99,996 shares.
- MATTHEW JAUCHIUS sold 6,527 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CMT Hedge Fund Activity
We have seen 41 institutional investors add shares of $CMT stock to their portfolio, and 47 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 163,900 shares (-100.0%) from their portfolio in Q3 2024
- TIETON CAPITAL MANAGEMENT, LLC added 104,515 shares (+58.9%) to their portfolio in Q3 2024
- GOLDMAN SACHS GROUP INC added 69,684 shares (+153.1%) to their portfolio in Q3 2024
- AQR CAPITAL MANAGEMENT LLC removed 51,756 shares (-40.6%) from their portfolio in Q3 2024
- JANNEY MONTGOMERY SCOTT LLC removed 28,900 shares (-100.0%) from their portfolio in Q3 2024
- RENAISSANCE TECHNOLOGIES LLC removed 28,200 shares (-5.4%) from their portfolio in Q3 2024
- MORGAN STANLEY removed 27,169 shares (-35.4%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
